Found 39 matching trials
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
PHASE1Patients with poor risk classical Hodgkin Lymphoma (cHL) will undergo myelo...
Location
New York Medical College
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
PHASE1Chimeric antigen receptor-modified T cells (CART) holds great promise for t...
Location
Chinese PLA General Hospital
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
EARLY_PHASE1This study is a single-center, open-label clinical trial of single-dose of ...
Location
Affiliated Hospital of Nantong University
National Project on Vaccines, COVID-19 and Frail Patients
N/AThis is a multicentre observational study with the aim of evaluating the an...
Location
IRCCS Istituto Tumori Giovanni Paolo II
Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma
PHASE1This is a phase 1 study to evaluate safety and dose-limiting toxicity of au...
Status
Active Not Recruiting
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
PHASE1The body has different ways of fighting infection and disease. No single wa...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)
PHASE1Currently, a majority of lymphomas cannot be cured by standard chemo-radiot...
Location
University of Florida
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma
PHASE1Patients with relapsed low-risk CD30 classical Hodgkin Lymphoma will have a...
Location
Multiple Locations
GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma
PHASE1Targeted therapy against the CD30 molecule has achieved some progress in CD...
Location
People's Liberation Army General Hospital
Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma
EARLY_PHASE1This study is an exploratory clinical trial of a single-center, open-label,...
Location
The First Affiliated Hospital of Anhui Medical University